Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 215, Issue 1, Pages 159-175
Publisher
Rockefeller University Press
Online
2017-11-15
DOI
10.1084/jem.20171052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabotropic glutamate receptors in cancer
- (2017) Lumeng J. Yu et al. NEUROPHARMACOLOGY
- Circulating Folate and Vitamin B 12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls
- (2016) Alison J. Price et al. EUROPEAN UROLOGY
- A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells
- (2016) Eswar Shankar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
- (2016) Kambiz Rahbar et al. JOURNAL OF NUCLEAR MEDICINE
- 225Ac-PSMA-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss
- (2016) Onur Cizmecioglu et al. eLife
- Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ
- (2015) Sarit Schwartz et al. CANCER CELL
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- (2015) N. Pandit-Taskar et al. CLINICAL CANCER RESEARCH
- Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo
- (2015) Heather Nesbitt et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
- (2015) Karine A. Cohen-Solal et al. Molecular Cancer
- Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
- (2015) Sven Perner et al. Oncotarget
- Predictive Value of PTEN and AR Coexpression of Sustained Responsiveness to Hormonal Therapy in Prostate Cancer—A Pilot Study
- (2015) Soha Salama El Sheikh et al. NEOPLASIA
- Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
- (2014) R. Dienstmann et al. MOLECULAR CANCER THERAPEUTICS
- Copy number alteration burden predicts prostate cancer relapse
- (2014) H. Hieronymus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
- (2013) N. Mitsiades CANCER RESEARCH
- PET/MR in prostate cancer: technical aspects and potential diagnostic value
- (2013) Michael Souvatzoglou et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- mTORC2 controls actin polymerization required for consolidation of long-term memory
- (2013) Wei Huang et al. NATURE NEUROSCIENCE
- mTORC2: actin on your memory
- (2013) Sheena A Josselyn et al. NATURE NEUROSCIENCE
- Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2
- (2013) René Martin et al. NUCLEAR MEDICINE AND BIOLOGY
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research
- (2013) Benjamin T. Ristau et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Dual fluorescent molecular substrates selectively report the activation, sustainability and reversibility of cellular PKB/Akt activity
- (2013) Duanwen Shen et al. Scientific Reports
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
- (2012) Matthias Eder et al. BIOCONJUGATE CHEMISTRY
- Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition
- (2012) K. A. Rahn et al. CURRENT MEDICINAL CHEMISTRY
- Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
- (2012) K. A. Rahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy
- (2012) David R. Yates et al. PROSTATE
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic Subunits
- (2010) Xinnong Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular circuits of solid tumors: prognostic and predictive tools for bedside use
- (2010) Charles Ferté et al. Nature Reviews Clinical Oncology
- Reaction Mechanism of Glutamate Carboxypeptidase II Revealed by Mutagenesis, X-ray Crystallography, and Computational Methods
- (2009) Vojtěch Klusák et al. BIOCHEMISTRY
- The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1
- (2009) Marco Colombatti et al. PLoS One
- Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate Carcinogenesis
- (2008) Veronica Yao et al. CANCER RESEARCH
- PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens
- (2008) Liqing Xiao et al. MOLECULAR CARCINOGENESIS
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
- (2008) Shidong Jia et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started